Cerus reported $-9848000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Atrion ATRI:US 7.84M 1.64M
Cerulean Pharma CERU:US $ -8400450 1.14M
Cerus CERS:US $ -9848000 2.89M
Cytori Therapeutics CYTX:US $ -3926000 285K
GRIFOLS GRF:SM 244.2M 75.33M
Haemonetics HAE:US $ 87.48M 45.7M
Meridian Bioscience VIVO:US $ 36.72M 16.15M
Nuvasive NUVA:US $ 14.99M 3.56M
Orasure Technologies OSUR:US $ -16014000 6.68M
Quidel QDEL:US $ 623.69M 239.16M
Sientra SIEN:US $ -16095000 2.37M
Staar Surgical STAA:US $ 12.11M 4.73M
Terumo 4543:JP 21.51B 7.09B
Utah Medical Products UTMD:US 5.1M 1.21M